Clinical Trial Update: Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1) [Phase 3]

View source ↗

Summary

A Phase 3 safety and efficacy trial (ASSIST-1) comparing iclaprim to linezolid for complicated skin and soft tissue infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Soft Tissue Infection

Drugs mentioned

• Iclaprim (iclaprim)
• Linezolid (Linezolid)

Snippet

Sponsor: Arpida AG | Conditions: Complicated Skin and Skin Structure Infection | Phase 3 | Status: COMPLETED